In a key decision earlier this month with potentially hefty ongoing implications for developers and property owners, the U.S. Court of Appeals for the Third Circuit held a chemical company liable for nearly $1 million in pre-acquisition cleanup costs.
A German court in Stuttgart has ordered Porsche SE to pay its investors for failing to provide timely information about the Volkswagen diesel emissions scandal.
On Friday, October 19, 2018, the Maryland Attorney General (AG) filed a petition for writ of certiorari to the United States Supreme Court (SCOTUS) regarding Maryland’s drug price gouging law (the Law)– the first state law enacted to prohibit alleged drug price gouging by manufacturers.
Efforts to update FDA’s personal care products regulations continue as Rep. Jan Schakowsky (D-IL) recently introduced H.R. 6903, the “Safe Cosmetics and Personal Care Products Act of 2018.”
Long-anticipated changes to California’s Proposition 65 warning requirements took effect on August 30, 2018, through amendments and new rules issued by the California Office of Environmental Health Hazard Assessment.
President Trump is expected to sign into law a bill which will – among other things – expand the scope of the Open Payments reporting requirements mandated by Section 6002 of the Patient Protection and Affordable Care Act (often referred to as the Sunshine Act).
Long-anticipated changes to California’s Proposition 65 warning requirements took effect on August 30, 2018, through amendments and new rules issued by the California Office of Environmental Health Hazard Assessment.
On September 28, 2018, the Pharmaceutical Research and Manufacturers of America (PhRMA) filed an amended complaint to revive its lawsuit seeking to block implementation and enforcement of California’s drug price transparency law.
In the last hour of the last day of last month, with 30 minutes to spare, US Trade Representative Lighthizer met the US self-imposed deadline and formally sent to Congress the agreed-upon text of a US-Mexico-Canada Agreement, or USMCA.
Last week, the Drug Enforcement Agency (DEA) published in the Federal Register its Final Order placing FDA-approved cannabidiol drug products (CBD) containing no more than 0.1 percent tetrahydrocannabinols in schedule V of the Controlled Substances Act.
California Gov. Jerry Brown, in a surprise move, vetoed a wide-ranging bill backed by the California New Car Dealers Association over his concerns regarding a formula automakers would have had to use to pay dealers for warranty and recall repairs.
US Customs and Border Protection’s Executive Assistant Commissioner of Field Operations, Todd Owen, recently spoke with Politico and confirmed that CBP will continue to apply long-standing US federal laws and regulations that treat marijuana as a banned substance at the US border.
